Take a closer look at the full table. The average price to earnings ratio (P/E ratio) amounts to 17.35 while the forward price to earnings ratio is 10.13. The dividend yield has a value of 3.28 percent. Price to book ratio is 2.81 and price to sales ratio 2.93. The operating margin amounts to 22.48 percent.
Best Stocks To Buy For 2014: Heska Corporation (HSKA)
Heska Corporation develops, manufactures, markets, sells, and supports veterinary products for canine and feline companion animal health markets in the United States and internationally. The companyÂ’s Core Companion Animal Health segment offers various veterinary diagnostic and other instruments, including The DRI-CHEM 4000 veterinary chemistry analyzer for blood chemistry and electrolyte analysis; HEMATRUE veterinary hematology analyzer, a blood analyzer that measures white blood cell count, red blood cell count, platelet count, and hemoglobin levels in animals; Accutrend Plus Lactate analyzer; and IV pumps. It also offers point-of-care diagnostic test products, such as heartworm diagnostic products for dogs and cats; veterinary diagnostic laboratory products and services, such as allergy diagnostic products and services; pharmaceuticals and supplements, including heartworm prevention products, nutritional supplements, and hypothyroid treatment products; and vaccines and other biologicals for allergy treatment and feline respiratory diseases, as well as sells consumable supplies. This segment sells its products to veterinarians through a field organization, a telephone sales force, and independent third-party distributors. Its Other Vaccines, Pharmaceuticals, and Products segment provides private label vaccine and pharmaceutical products for cattle, as well as for other animals that include small mammals and fish. It offers bovine products, and biological and pharmaceutical products for other animal health companies; and provides various turnkey services comprising research, licensing, production, labeling, and packaging of products, as well as validation support and distribution services. This segment sells its products through third parties under third party labels. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. Heska Corporation was founded in 1988 and is headquartered in Loveland, Colo rado.Advisors' Opinion:
- [By ChemTrade]
This stock was trading just over $9 earlier this month when I wrote an article (Little Known Dividend Stock That Could Double in 2012) detailing why it is a strong candidate for a double-bagger this year. Prices jumped close to $12 over the past couple weeks since I wrote that piece.
What makes HSKA a timely buy in a pullback? HSKA announced a quarterly dividend of 10 cents per share last month. This shows confidence in future cash flows. The niche market of animal diagnostics gives HSKA strong buyout potential. Remember the pet diagnostic company Synbiotics that was bought out by Pfizer (PFE) at three to four times the publicly traded value? Other big pharma companies may follow suit and target HSKA which has a strong upcoming pipeline of products.
A small pullback caused by the market would make an excellent time to accumulate shares for those investors that missed out on the first opportunity when shares were at $9 a few weeks ago.
Best Stocks To Buy For 2014: Select Harvests Ltd(SHV.AX)
Select Harvests Limited engages in processing, packaging, marketing, and distributing edible nuts, dried fruits, seeds, and a range of natural health foods. It is also involved in growing, processing, and selling almonds to the food industry. As of June 30, 2011, the company owned a total of 6,254 acres of almond orchards and leased a total of 4,521 acres of almond orchards located in located in Victoria, New South Wales, and Western Australia. In addition, it provides management services to external owners of almond orchards, including orchard development, tree supply, farm management, land rental, and irrigation infrastructure, as well as markets and sells almonds on behalf of external investors. Select Harvests Limited markets and distributes its nuts and fruit based products in Australia, as well as exports to Asia, Europe, and the Middle East. The company offers its food products under the Lucky, Sunsol, Nu-Vit, Soland, and Meriram brand names. Select Harvests Limited is based in Thomastown, Australia.
Best Stocks To Buy For 2014: Stryker Corporation(SYK)
Stryker Corporation, together with its subsidiaries, operates as a medical technology company worldwide. The company operates in three segments: Reconstructive, MedSurg, and Neurotechnology and Spine. The Reconstructive segment offers orthopaedic reconstructive (hip and knee) and trauma implant systems, as well as other related products. The MedSurg segment provides surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; and other related products. The Neurotechnology and Spine segment offers neurovascular products, spinal implant systems, and other related products. The company sells its products through local dealers and direct sales force to doctors, hospitals, and other healthcare facilities, as well as through third-party dealers and distributors in the United States, Europe, the Middle East, Africa, and Japan, Canada, the Pacific region, and the Latin America region. Stryker Corporat ion was founded in 1941 and is headquartered in Kalamazoo, Michigan.Advisors' Opinion:
- [By James K. Glassman]
Stryker (symbol: SYK) is a large, skillfully managed maker of medical devices, including hip and knee implants. Currently trading at 13 times projected 2013 earnings, Stryker is one of those companies you can stash in your IRA for a few decades and profit from as the world ages.
- [By Sam Collins]
Global specialty surgical and medical products company, Stryker Corporation (NYSE: SYK), is expected to have a 12% rise in sales this year, led by the acquisition of Boston Scientific Corporation’s (NYSE: BSX) neurovascular unit.?
S&P looks for earnings of $3.72 this year, up from $3.33, and they project earnings of $4.15 in 2012. On Feb. 23, UBS raised SYK to a “buy” from a “hold.”?
Technically, the break from the double-top could give a trading target of $74.
- [By Conrad de Aenlle]
This medical technology company just hit a 52-week high, but Morningstar finds plenty of growth potential left in it. The stock is still 12 percent below fair value, the report says, and is expected to produce a 14.3 percent annualized return.
Best Stocks To Buy For 2014: Jabil Circuit Inc.(JBL)
Jabil Circuit, Inc., together with its subsidiaries, provides electronic manufacturing services and solutions worldwide. The company offers electronics and mechanical design, production, product management, and after-market services to companies in the aerospace, automotive, computing, consumer, defense, industrial, instrumentation, medical, networking, peripherals, solar, storage, and telecommunications industries. Its services comprise integrated design and engineering; component selection, sourcing, and procurement; automated assembly; design and implementation of product testing; parallel global production; enclosure services; and systems assembly, direct-order fulfillment, and configure-to-order services. The company also provides set-top boxes, mobility products, and display products, as well as peripheral products, such as printers and point of sale terminals; and aftermarket services consisting of warranty and repair services. Jabil Circuit, Inc. was founded in 196 6 and is headquartered in St. Petersburg, Florida.Advisors' Opinion:
- [By Nelson]
Jabil Circuit (JBL) is the best stock idea for 2012 in this sector due to an expected margin improvement and above-peer growth from its growing materials business, an after-market services business, and an increasing number of opportunities in outsourced manufacturing. Almost 40% of JBL’s revenue comes from these opportunities and they have margins well-above the corporate average. Jabil’s stock is trading at $20.86 and is expected to reach a t arget price of $22. Market capitalization for the company stands at $4.34 billion and it has earnings per share of $2.34 which are expected to go north of $2.83. P/E stands at only 8x.
Best Stocks To Buy For 2014: Stereotaxis Inc.(STXS)
Stereotaxis, Inc. designs, manufactures, and markets cardiology instrument control systems for use in a hospital?s interventional surgical suite or interventional lab for the treatment of arrhythmias and coronary artery diseases in the United States and internationally. The company provides Niobe system, which includes Niobe Magnetic Navigation System that navigates catheters, guidewires, and other delivery devices through complex paths in the blood vessels and chambers of the heart to carry out treatment; Navigant, a user interface or physician control center, which physicians use to visualize and track procedures and to provide instrument control commands that govern the motion of the working tip of the catheter, guidewire, or other interventional device; Cardiodrive, a catheter advancement system to remotely advance and retract the catheter in the patient?s heart. It also offers Odyssey enterprise solutions, which provides information solutions to manage, control, rec ord, and share procedures across networks; acquires remote view of the lab capturing synchronized procedure data for review of important events during cases; and review recorded cases and create snapshots following procedures for clinical reporting, auditing, and presentation. In addition, the company provides disposable interventional devices comprising automated catheters, coronary guidewires, and navigation and ablation systems. It markets its products through its direct sales force, distributors, and sales agents. The company was founded in 1990 and is headquartered in St. Louis, Missouri.